Cargando…
Xenograft models for pediatric cancer therapies
The prognosis for childhood cancer has improved considerably over the past 50 years. This improvement is attributed to well-designed clinical trials which have incorporated chemotherapy, surgery, and radiation. With an increased understanding of cancer biology and genetics, we have entered an era of...
Autores principales: | McNerney, Kevin O, Teachey, David T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty Opinions Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894265/ https://www.ncbi.nlm.nih.gov/pubmed/33659929 http://dx.doi.org/10.12703/r/10-11 |
Ejemplares similares
-
The Role of PF4 Antibodies in Pediatric Sars-Cov-2 Infections
por: Chiem, Meady, et al.
Publicado: (2021) -
Clinical Trials on Cellular Therapy for Children and Adolescents With Cancer: A 15-Year Trend in the United States
por: Cho, Sukjoo, et al.
Publicado: (2023) -
Diagnostics for Developing Countries
por: McNerney, Ruth
Publicado: (2015) -
Beginning Bazel: Building and Testing for Java, Go, and More
por: McNerney, PJ
Publicado: (2019) -
Congenital Atresia of the Aortic Orifice
por: McNerney, John C.
Publicado: (1937)